Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Postbariatric Hypoglycemia”

10 trials

Showing 10 of 10 results

Testing effectiveness (Phase 2)Study completedNCT03373435
What this trial is testing

Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia

Who this might be right for
Postbariatric Hypoglycemia
Eiger BioPharmaceuticals 18
Early research (Phase 1)Study completedNCT06036784
What this trial is testing

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects

Who this might be right for
Postbariatric Hypoglycemia
MBX Biosciences 69
Not applicableLooking for participantsNCT06896682
What this trial is testing

Cortisol and Obesity - A Vicious Cycle? Hypoglycemia After Bariatric Surgery - Association With Cortisol Metabolism?

Who this might be right for
Postbariatric Hypoglycemia
Esbjerg Hospital - University Hospital of Southern Denmark 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07760961
What this trial is testing

Effect of Mizagliflozin on Hypoglycemia in Patients With Post-Bariatric Hypoglycemia

Who this might be right for
Postbariatric Hypoglycemia
Vogenx, Inc. 36
Large-scale testing (Phase 3)Looking for participantsNCT05401578
What this trial is testing

Canakinumab for the Treatment of Postprandial Hypoglycemia

Who this might be right for
Postprandial Hypoglycemia
University Hospital, Basel, Switzerland 56
Large-scale testing (Phase 3)Ended earlyNCT05036317
What this trial is testing

Empagliflozin for the Treatment of Postprandial Hypoglycemia

Who this might be right for
Postprandial Hypoglycemia
University Hospital, Basel, Switzerland 40
Testing effectiveness (Phase 2)Study completedNCT05541939
What this trial is testing

Effect of Mizagliflozin on Postprandial Glucose and Insulin in Post-Bariatric Hypoglycemia Subjects

Who this might be right for
Postbariatric Hypoglycemia
Vogenx, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT07029412
What this trial is testing

Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)

Who this might be right for
Postbariatric Hypoglycemia
MBX Biosciences 20
Testing effectiveness (Phase 2)Study completedNCT05721729
What this trial is testing

Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions

Who this might be right for
Postbariatric Hypoglycemia
Vogenx, Inc. 15
Not applicableStudy completedNCT03609632
What this trial is testing

Understanding Hypoglycaemia After Bariatric Surgery

Who this might be right for
Bariatric Surgery
Insel Gruppe AG, University Hospital Bern 16

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation